I-Mab Makes Executive Appointment

I-Mab, a clinical stage biopharmaceutical company, has appointed Gigi Feng as vice president, global head of corporate communications, effective April 20, 2020. Reporting to I-Mab’s board of directors, Feng will oversee all communications across I-Mab, partnering with the executive team to communicate the company’s strategic narrative, R&D innovation, external collaborations and more.
 
"We are very excited at the prospect of Gigi leading our domestic and global communications efforts as we are growing rapidly towards a fully integrated global biopharma," said Dr. Jingwu Zang, founder and honorary chairman of the board, I-Mab. "Gigi is a talented communications leader and brings to the company a wealth of global experience across the healthcare sector, which will be key to building I-Mab’s capability to effectively communicate with various key stakeholders, including media, business partners, health professionals and regulators."
 
Feng most recently served as Amgen’s Japan Asia Pacific regional head of corporate affairs, where she led communications efforts including executive communications, media relations, employee engagement and philanthropy to build the Amgen brand across 14 markets in the Asia Pacific region. Before joining Amgen, Feng held a series of communications leadership roles at Sanofi.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.